Onxeo to Present at the 11th Edition of the “Rencontres de la Cancérologie Française” Oncology Conference

Paris, October 3, 2018 – 5:45 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant cancers, today announced its participation in the 11th edition of the Rencontres de la Cancérologie Française (RCFr), a major event dedicated to innovation in oncology to be held on 27 and 28 November 2018 in Paris.

This edition on the theme of “Anticipation in cancer” will be inaugurated by the French Minister of Health, Mrs Agnès Buzyn.

On this occasion, ONXEO will address a panel of experts during the session “Valorisation des projets scientifiques de technologies émergentes” (Valuation of scientific projects for emerging technologies), organized in partnership with the École polytechnique and Angels Santé.

“We are pleased to participate in this event and to have the opportunity to present to experts our lead project AsiDNA™ in the promising field of DNA damage response,” said Olivier de Beaumont, Medical Director of Onxeo.

 

Session: Valuation of scientific projects for emerging technologies

Date: Tuesday, November 27, 2018

Time: 7:45 pm

Location: Chatoform’ Eurosites George V (Paris), France

181003_PR_Onxeo_RCFr18